Cattle producers and veterinarians now have a new option for control of Bovine Respiratory Disease (BRD) in beef and non-lactating dairy cattle at high risk of developing BRD. Baytril 100 (enrofloxacin) Injectable, manufactured by Bayer HealthCare LLC, Animal Health Division, has been approved by the Food and Drug Administration (FDA) for control of all four major BRD pathogens.
With the latest approval from FDA, Baytril 100 is the first and only fluoroquinolone approved for treatment of BRD and control of BRD in high-risk cattle, providing flexibility in treatment protocols.
Cattle producers and veterinarians now can rely on Baytril 100 for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non‑lactating dairy cattle; and, for the control of BRD in beef and non-lactating dairy heifers less than 20 months of age at high risk of developing BRD associated with M.haemolytica, P. multocida, H. somni and M. bovis.
BRD has a significant health and economic impact on cattle operations across the country. Particularly susceptible are cattle at high risk of developing infections due to stress and exposure to other cattle.
High-risk factors for cattle can include:
- Transportation with animals from two or more farm origins
- Extended transport time with few to no rest stops
- Environmental temperature changes of ≥30°F between locations, within a
24-hour period upon arrival
- Exposure to wet or cold weather conditions
- Excessive shrink (more than would be expected with normal load of cattle)
- Stressful arrival processing procedures, such as castration or dehorning
- Exposure within previous 72 hours to animals showing clinical signs of BRD
“BRD in dairy replacement heifers have long-term, devastating consequences for the future of the herd,” said Keith Sterner, D.V.M., practitioner in Ionia, Mich. “Early diagnosis and treatment of these pathogens are critical to help prevent irreparable damage to young and particularly susceptible animals.”
In the lab, Baytril 100 kills 97 percent of the key BRD-causing bacteria in one to two hours1,2 in vitro.* In a clinical field study, Baytril 100 demonstrated statistically significant control of BRD in high-risk cattle in a 14-day study3.
“In 2011, this antibiotic was approved for treatment of Mycoplasma bovis, which is a very challenging pathogen for dairy replacement heifer operations,” said Todd Firkins, Livestock Category Manager, Food Animal Products, Bayer HealthCare Animal Health division. “With the option of Baytril 100 as a control tool for BRD in high-risk heifers, producers and veterinarians now can treat their cattle more efficiently to kill BRD and help the calf’s immune system get back to work.”